Contribution of lung function tests to the staging of severe equine asthma syndrome in the field.

This research focuses on improving the clinical staging method for Severe Equine Asthma Syndrome (SEAS) by incorporating lung function tests. It presents a new disease staging model that has been proven to be very effective in identifying and staging SEAS.

Staging of Severe Equine Asthma Syndrome (SEAS)

• The research deals with Severe Equine Asthma Syndrome (SEAS), a prevalent medical condition in the equine population. It emphasizes the importance of an effective, clinically-based staging method for the disease which is critical for monitoring progress and treatment response.
• Earlier models, which the same team had developed, have laid the groundwork for the present study. This one focusses on incorporating lung function tests outcomes to provide a more detailed perspective in disease staging.

Lung Function Tests and Disease Staging

• The study employs discriminant analysis to derive a new staging method that can be used under practical field conditions.
• The method involved observation of differences between group means. It specifically observed the clinical score, bronchoalveolar lavage fluid neutrophil percentage, pleural pressure (ΔPpl), PaO and histamine concentration.

Efficiency of New Disease Staging Model

• The linear functions derived from this method accounted for approximately 99.3% of the data variability. An impressive 94.7% of the cases were grouped correctly, and cross-validation of the results evidenced an 86.8% rating.
• The research, therefore, concludes that this staging model exhibits an excellent outcome. It can be used as a tool not only within the confines of field conditions but also within diagnostic and research centres.
• This enhancement to the staging of SEAS can potentially streamline the disease management process, making it more efficient and effective.